<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mass spectrometry-based analyses of the low-molecular-weight fraction of serum proteome allow identifying proteome profiles (signatures) that are potentially useful in detection and diagnostics of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Here we compared serum proteome profiles of healthy donors and patients with three different types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> aiming to identify <z:chebi fb="7" ids="16670">peptide</z:chebi> signatures that were either common for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> samples or specific for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type </plain></SENT>
<SENT sid="2" pm="."><plain>Blood samples were collected before start of the therapy from patients with head and neck <z:e sem="disease" ids="C0007137,C0751688" disease_type="Neoplastic Process" abbrv="">squamous cell cancer</z:e>, colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and <z:e sem="disease" ids="C0007131" disease_type="Neoplastic Process" abbrv="NSCLC">non-small cell lung cancer</z:e>, and from a corresponding group of healthy volunteers </plain></SENT>
<SENT sid="3" pm="."><plain>Mass profiles of the serum proteome were recorded in the range between 2 and 13 kDa using MALDI-ToF spectrometry and 131 identified <z:chebi fb="7" ids="16670">peptide</z:chebi> ions were used for statistical analyses </plain></SENT>
<SENT sid="4" pm="."><plain>Similar degrees of overall similarities were observed in <z:hpo ids='HP_0000001'>all</z:hpo> intra-group and inter-group analyses when general features of serum proteome profiles were compared between individual samples </plain></SENT>
<SENT sid="5" pm="."><plain>However, classifiers built of selected spectral components allowed differentiation between healthy donors and three groups of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients with 69-74% sensitivity and 82-84% specificity </plain></SENT>
<SENT sid="6" pm="."><plain>There were two common <z:chebi fb="7" ids="16670">peptide</z:chebi> species (3766 and 5867 Da) with increased levels in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> samples </plain></SENT>
<SENT sid="7" pm="."><plain>Several spectral components permitted differentiation between <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> samples and either <z:e sem="disease" ids="C0278996" disease_type="Neoplastic Process" abbrv="">head and neck cancer</z:e> or <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> samples, but two latter types of samples could not be properly discriminated </plain></SENT>
<SENT sid="8" pm="."><plain>Abundance of spectral components that putatively corresponded to fragments of serum amyloid A (11511 and 11667 Da) was highest in <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> samples, yet increased levels of these <z:chebi fb="7" ids="16670">peptides</z:chebi> appeared to generally associate with more <z:e sem="disease" ids="C0877373" disease_type="Neoplastic Process" abbrv="">advanced cancer</z:e> cases </plain></SENT>
<SENT sid="9" pm="."><plain>We concluded that certain components of serum <z:chebi fb="7" ids="16670">peptide</z:chebi> signatures are common for different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> signatures and putatively reflect general response of organism to the disease, yet other components of such signatures are more specific and most likely correspond to clinical stage of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>